• Profile
Close

Improvement of mortality prognostication in patients with epidermal necrolysis: The role of novel inflammatory markers and proposed revision of SCORTEN (Re-SCORTEN)

JAMA Jan 05, 2022

Koh HK, Fook-Chong SMC, Lee HY, et al. - Researchers investigated the utility of novel inflammatory markers such as red cell distribution width to hemoglobin ratio (RDW/Hb) in prognostication of mortality in patients with epidermal necrolysis.

  • A retrospective cohort study of 192 patients was conducted over a 17-year period in an Asian reference center.

  • There appeared a strong predictive value of RDW/Hb for in-hospital mortality and bacteremia.

  • RDW/Hb showed similar discrimination to the Severity-of-Illness Score for Toxic Epidermal Necrolysis (SCORTEN), which is the most commonly used prognostic score in epidermal necrolysis.

  • Addition of RDW/Hb to SCORTEN resulted in improvement of the predictive accuracy of the composite score (Re-SCORTEN).

  • Overall findings support the utility of measuring RDW/Hb in addition to SCORTEN in improving the mortality prognostication of epidermal necrolysis.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay